F-FDG PET/MR 改善初诊转移性尿道腺癌的评估
F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma.
作者信息
Laudicella Riccardo, Davidzon Guido, Vasanawala Shreyas, Baldari Sergio, Iagaru Andrei
机构信息
1Department of Biomedical and Dental Sciences and of Morpho-functional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy.
2Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, USA.
出版信息
Nucl Med Mol Imaging. 2019 Aug;53(4):296-299. doi: 10.1007/s13139-019-00597-8. Epub 2019 Jun 12.
We described the clinical impact of F-FDG PET/MR in refining the evaluation of a 39-year-old female with newly diagnosed metastatic urethral adenocarcinoma. We detailed the diagnostic imaging workup focusing our attention on the CT, MR, and F-FDG PET/MR different findings. In this case, F-FDG PET/MR imaging evaluation resulted not only effective but also altered staging and spared additional invasive procedures in the assessment of a metastatic urethral adenocarcinoma. Combining a highly sensitive PET with the increase tissue resolution of MR (PET/MR) may improve abdominal and pelvic lesion detection outperforming PET/CT for this indication.
我们描述了18F-氟代脱氧葡萄糖正电子发射断层显像/磁共振成像（18F-FDG PET/MR）在优化一名新诊断为转移性尿道腺癌的39岁女性患者评估中的临床影响。我们详细介绍了诊断性影像学检查，重点关注计算机断层扫描（CT）、磁共振成像（MR）及18F-FDG PET/MR的不同表现。在此病例中，18F-FDG PET/MR成像评估不仅有效，还改变了分期，并且在转移性尿道腺癌评估中避免了额外的侵入性检查。将高灵敏度的PET与MR增强的组织分辨率相结合（PET/MR），在该适应证中可能比PET/CT更能提高腹部和盆腔病变的检出率。
Zotero 插件